Tag: Leukaemia

Search News
Categories
Archives
Introducing Dr Özgen Deniz

21st December 2022

We are pleased to welcome Dr Özgen Deniz to Barts Cancer Institute (BCI) at Queen Mary University of London as a Lecturer and Group Leader. After receiving a Cancer Research UK Career Development Fellowship, Dr Deniz is establishing her own independent research group in BCI’s Centre for Haemato-Oncology.

Read more

BCI researcher part of Strategic Collaboration Agreement with Queen Mary, Envisagenics and Cancer Research Horizons

14th December 2022

BCI’s Dr Ana Rio-Machin is part of a new research collaboration agreement that will leverage Envisagenics’ SpliceCore® AI platform for expanded discovery and research in haematopoietic cancers.

Read more

Rewiring the biology of leukaemia cells to reverse drug resistance

20th April 2022

Researchers from Barts Cancer Institute at Queen Mary University of London have identified a way to reverse resistance to a group of cancer drugs, known as kinase inhibitors, in leukaemia cells. By rewiring the inner workings of the cancer cells, the team was able to prime leukaemia cells for sensitivity to treatment in the laboratory.

Read more

Barts Cancer Institute at ASH 2021

17th December 2021

In December each year, the American Society of Hematology (ASH) hosts its Annual Meeting and Exposition – the premier event in malignant and non-malignant haematology. The event represents an invaluable opportunity for researchers at Barts Cancer Institute, Queen Mary University of London to highlight their blood cancer research on an international stage.

Read more

Mapping the emergence of treatment resistance in leukaemia

28th September 2021

Research led by Barts Cancer Institute, Queen Mary University of London, has identified a new role for a group of cells called adipocytes in contributing to treatment resistance in a type of leukaemia. Published in Nature Communications, the findings broaden the understanding of resistance pathways in blood cancer cells, which is critical for developing novel treatment strategies to improve outcomes for people with leukaemia.

Read more

Tackling blood cancer with Blood Cancer UK

10th September 2021

This Blood Cancer Awareness Month, find out about the Blood Cancer UK-funded research projects currently underway at the Barts Cancer Institute, which span from looking at the specific genetic changes that drive blood cancer development, to identifying new treatment strategies to improve the outcomes for patients.

Read more

Search News
Categories
Archives